Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical ExperienceGilles Salles(Université Claude Bernard Lyon 1), David G. Maloney(Fred Hutch Cancer Center)Advances in TherapyOctober 1, 201710.1007/s12325-017-0612-xCited by 603SaveCiteExport RISWatch citationsRelated PapersPharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis|Blood|2008|39